Pushing the Boundaries of Treatment: A Q&A with Uyen To
Uyen To, MD, assistant professor of medicine (digestive diseases) and transplant hepatologist, discusses how she first became interested in studying Wilson
Stay updated with breaking news from Michael Schilsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Uyen To, MD, assistant professor of medicine (digestive diseases) and transplant hepatologist, discusses how she first became interested in studying Wilson
Phase III study results led to trientine tetrahydrochloride's FDA approval for this rare disorder
Orphalan announces publication of results from the CHELATE trial in The Lancet Gastroenterology & Hepatology Trial supported Orphalan's successful application to the United States Food and
Orphalan announces data from secondary analyses of the CHELATE trial for maintenance patients with Wilson's Disease - Data from the company's CHELATE trial to be presented today during an oral presentation
Investegate announcements from Orphalan, Orphalan announces data from secondary analyses of the CHELATE trial for maintenance patients with Wilson’s Disease